Associations between genetically predicted plasma N-glycans and pancreatic cancer risk

References

• Akmačić IT, Ugrina I, Štambuk J, Gudelj I, Vučković F, Lauc G, Pučić-Baković M. 2015. High-throughput glycomics: optimization of sample preparation. Biochemistry (Mosc). 80(7):934–942. doi:10.1134/S0006297915070123.
   PubMed Web of Science ®Google Scholar
• Allegri M, De Gregori M, Minella CE, Klersy C, Wang W, Sim M, Gieger C, Manz J, Pemberton IK, MacDougall J, et al. 2016. ‘Omics’ biomarkers associated with chronic low back pain: protocol of a retrospective longitudinal study. BMJ Open. 6(10):e012070. doi:10.1136/bmjopen-2016-012070.
   PubMed Web of Science ®Google Scholar
• Bellis SL, Reis CA, Varki A, Kannagi R, Stanley P, Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, et al. 2022. Glycosylation changes in cancer. In: Essentials of glycobiology [internet]. 4th edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; Chapter 47.
   Google Scholar
• Briggs MT, Condina MR, Klingler-Hoffmann M, Arentz G, Everest-Dass AV, Kaur G, Oehler MK, Packer NH, Hoffmann P. 2019. Translating N-glycan analytical applications into clinical strategies for ovarian cancer. Proteomics Clin Appl. 13(3):1800099. doi:10.1002/prca.201800099.
   PubMed Web of Science ®Google Scholar
• Brion MJ, Shakhbazov K, Visscher PM. 2013. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 42:1497–1501. doi:10.1093/ije/dyt179.
   PubMed Web of Science ®Google Scholar
• Burgess S, Butterworth A, Thompson SG. 2013. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 37(7):658–665. doi:10.1002/gepi.21758.
   PubMed Web of Science ®Google Scholar
• Chen H, Deng Z, Huang C, Wu H, Zhao X, Li Y. 2017. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression. Tumor Biol. 39(7):1010428317716249.
   Google Scholar
• de Leoz ML, Young LJ, An HJ, Kronewitter SR, Kim J, Miyamoto S, Borowsky AD, Chew HK, Lebrilla CB. 2011. High-mannose glycans are elevated during breast cancer progression. Mol Cell Proteomics. 10(1):M110.002717. doi:10.1074/mcp.M110.002717.
   PubMed Web of Science ®Google Scholar
• Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW. 1995. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol. 130(2):383–392. doi:10.1083/jcb.130.2.383.
   PubMed Web of Science ®Google Scholar
• Doherty M, Theodoratou E, Walsh I, Adamczyk B, Stöckmann H, Agakov F, Timofeeva M, Trbojević-Akmačić I, Vučković F, Duffy F, et al. 2018. Plasma N-glycans in colorectal cancer risk. Sci Rep. 8(1):8655. doi:10.1038/s41598-018-26805-7.
   PubMedGoogle Scholar
• Everest-Dass AV, Briggs MT, Kaur G, Oehler MK, Hoffmann P, Packer NH. 2016. N-glycan MALDI imaging mass spectrometry on formalin-fixed paraffin-embedded tissue enables the delineation of ovarian cancer tissues. Mol Cell Proteomics. 15(9):3003–3016. doi:10.1074/mcp.M116.059816.
   PubMed Web of Science ®Google Scholar
• Ghoneim DH, Zhu J, Zheng W, Long J, Murff HJ, Ye F, Setiawan VW, Wilkens LR, Khankari NK, Haycock P, et al. 2020. Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 29(12):2735–2739. doi:10.1158/1055-9965.EPI-20-0651.
   PubMed Web of Science ®Google Scholar
• Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat. Med. 6(3):306–312. doi:10.1038/73163.
   PubMed Web of Science ®Google Scholar
• Greco B, Malacarne V, De Girardi F, Scotti GM, Manfredi F, Angelino E, Sirini C, Camisa B, Falcone L, Moresco MA, et al. 2022. Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies. Sci Transl Med. 14(628):eabg3072. doi:10.1126/scitranslmed.abg3072.
   PubMed Web of Science ®Google Scholar
• Guo J, Liu C, Zhou X, Xu X, Deng L, Li X, Guan F. 2017. Conditioned medium from malignant breast cancer cells induces an emt-like phenotype and an altered N-glycan profile in normal epithelial MCF10A cells. Int J Mol Sci. 18(8):1528. doi:10.3390/ijms18081528.
   PubMed Web of Science ®Google Scholar
• Hakomori S. 2002. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA. 99(16):10231–10233. doi:10.1073/pnas.172380699.
   PubMed Web of Science ®Google Scholar
• Herrera H, Dilday T, Uber A, Scott D, Zambrano JN, Wang M, Angel PM, Mehta AS, Drake RR, Hill EG, et al. 2019. Core-fucosylated tetra-antennary N-glycan containing A single N-acetyllactosamine branch Is associated with poor survival outcome in breast cancer. Int J Mol Sci. 20(10):2528. doi:10.3390/ijms20102528.
   PubMed Web of Science ®Google Scholar
• Hua S, An HJ, Ozcan S, Ro GS, Soares S, DeVere-White R, Lebrilla CB. 2011a. Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. Analyst. 136(18):3663–3671. doi:10.1039/c1an15093f.
   PubMed Web of Science ®Google Scholar
• Hua S, Lebrilla C, An HJ. 2011b. Application of nano-LC-based glycomics towards biomarker discovery. Bioanalysis. 3(22):2573–2585. doi:10.4155/bio.11.263.
   PubMed Web of Science ®Google Scholar
• Hua S, Williams CC, Dimapasoc LM, Ro GS, Ozcan S, Miyamoto S, Lebrilla CB. 2013. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J Chromatogr A. 1279:58–67. doi:10.1016/j.chroma.2012.12.079.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Yoneyama T, Tobisawa Y, Hatakeyama S, Kurosawa T, Nakamura K, Narita S, Mitsuzuka K, Duivenvoorden W, Pinthus JH, et al. 2017. An automated micro-total immunoassay system for measuring cancer-associated α2, 3-linked sialyl N-glycan-carrying prostate-specific antigen may improve the accuracy of prostate cancer diagnosis. Int J Mol Sci. 18(2):470. doi:10.3390/ijms18020470.
   PubMed Web of Science ®Google Scholar
• Kizuka Y, Taniguchi N. 2016. Enzymes for N-glycan branching and their genetic and nongenetic regulation in cancer. Biomolecules. 6(2):25. doi:10.3390/biom6020025.
   PubMed Web of Science ®Google Scholar
• Klarić L, Tsepilov YA, Stanton CM, Mangino M, Sikka TT, Esko T, Pakhomov E, Salo P, Deelen J, McGurnaghan SJ, et al. 2020. Glycosylation of immunoglobulin G is regulated by a large network of genes pleiotropic with inflammatory diseases. Sci Adv. 6(8):eaax0301. doi:10.1126/sciadv.aax0301.
   PubMed Web of Science ®Google Scholar
• Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, et al. 2018. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Commun. 9(1):1–11. doi:10.1038/s41467-017-02088-w.
   PubMedGoogle Scholar
• Kodar K, Stadlmann J, Klaamas K, Sergeyev B, Kurtenkov O. 2012. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: relation to tumor progression and survival. Glycoconj J. 29(1):57–66. doi:10.1007/s10719-011-9364-z.
   PubMed Web of Science ®Google Scholar
• Lauc G, Huffman JE, Pučić M, Zgaga L, Adamczyk B, Mužinić A, Novokmet M, Polašek O, Gornik O, Krištić J, et al. 2013. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet. 9(1):e1003225. doi:10.1371/journal.pgen.1003225.
   PubMed Web of Science ®Google Scholar
• Leek JT. 2014. svaseq: removing batch effects and other unwanted noise from sequencing data. Nucleic Acids Res. 42(21):e161. doi:10.1093/nar/gku864.
   PubMed Web of Science ®Google Scholar
• Levink IJM, Klatte DCF, Hanna-Sawires RG, Vreeker GCM, Ibrahim IS, van der Burgt YEM, Overbeek KA, Koopmann BDM, Cahen DL, Fuhler GM, et al. 2022. Longitudinal changes of serum protein N-glycan levels for earlier detection of pancreatic cancer in high-risk individuals. Pancreatology. 22(4):497–506. doi:10.1016/j.pan.2022.03.021.
   PubMed Web of Science ®Google Scholar
• Liu D, Zhou D, Sun Y, Zhu J, Ghoneim D, Wu C, Yao Q, Gamazon ER, Cox NJ, Wu L. 2020. A transcriptome-wide association study identifies candidate susceptibility genes for pancreatic cancer risk. Cancer Res. 80(20):4346–4354. doi:10.1158/0008-5472.CAN-20-1353.
   PubMed Web of Science ®Google Scholar
• Liu D, Zhu J, Zhao T, Sharapov S, Tiys E, Wu L. 2021. Associations between genetically predicted plasma N-glycans and prostate cancer risk: analysis of over 140,000 European descendants. Pharmgenomics Pers Med. 14:1211–1220.
   PubMed Web of Science ®Google Scholar
• Liu L, Yan B, Huang J, Gu Q, Wang L, Fang M, Jiao J, Yue X. 2013. The identification and characterization of novel N-glycan-based biomarkers in gastric cancer. PloS one. 8(10):e77821. doi:10.1371/journal.pone.0077821.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Hatakeyama S, Yoneyama T, Tobisawa Y, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Ito H, Nishimura SI, et al. 2019. Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer. Sci Rep. 9(1):1–8. doi:10.1038/s41598-018-37186-2.
   PubMedGoogle Scholar
• Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, et al. 2017. Association analysis identifies 65 new breast cancer risk loci. Nature. 551(7678):92–94. doi:10.1038/nature24284.
   PubMed Web of Science ®Google Scholar
• Moayyeri A, Hammond CJ, Hart DJ, Spector TD. 2013. The UK Adult Twin Registry (TwinsUK Resource). Twin Res Hum Genet. 16(1):144–149. doi:10.1017/thg.2012.89.
   PubMed Web of Science ®Google Scholar
• Mook-Kanamori DO, Selim MM, Takiddin AH, Al-Homsi H, Al-Mahmoud KA, Al-Obaidli A, Zirie MA, Rowe J, Yousri NA, Karoly ED, et al. 2014. 1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. J Clin Endocrinol Metab. 99(3):E479–E483. doi:10.1210/jc.2013-3596.
   PubMed Web of Science ®Google Scholar
• Moore A, Donahue T. 2019. Pancreatic cancer. Jama. 322(14):1426. doi:10.1001/jama.2019.14699.
   PubMedGoogle Scholar
• Moremen KW, Tiemeyer M, Nairn AV. 2012. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol. 13(7):448–462. doi:10.1038/nrm3383.
   PubMed Web of Science ®Google Scholar
• Munkley J. 2019. The glycosylation landscape of pancreatic cancer. Oncol Lett. 17(3):2569–2575.
   PubMed Web of Science ®Google Scholar
• Munkley J, Elliott DJ. 2016. Hallmarks of glycosylation in cancer. Oncotarget. 7:35478–35489. doi:10.18632/oncotarget.8155.
   PubMed Web of Science ®Google Scholar
• Park HM, Hwang MP, Kim YW, Kim KJ, Jin JM, Kim YH, Yang YH, Lee KH, Kim YG. 2015. Mass spectrometry-based N-linked glycomic profiling as a means for tracking pancreatic cancer metastasis. Carbohydr Res. 413:5–11. doi:10.1016/j.carres.2015.04.019.
   PubMed Web of Science ®Google Scholar
• Peng W, Goli M, Mirzaei P, Mechref Y. 2019. Revealing the biological attributes of N-glycan isomers in breast cancer brain metastasis using porous graphitic carbon (PGC) liquid chromatography-tandem mass spectrometry (LC-MS/MS). J Proteome Res. 18(10):3731–3740. doi:10.1021/acs.jproteome.9b00429.
   PubMed Web of Science ®Google Scholar
• Pinho SS, Reis CA. 2015. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 15(9):540–555. doi:10.1038/nrc3982.
   PubMed Web of Science ®Google Scholar
• Ruhaak LR, Stroble C, Dai J, Barnett M, Taguchi A, Goodman GE, Miyamoto S, Gandara D, Feng Z, Lebrilla CB, et al. 2016. Serum glycans as risk markers for non-small cell lung cancer. Cancer Prev Res (Phila). 9(4):317–323. doi:10.1158/1940-6207.CAPR-15-0033.
   PubMed Web of Science ®Google Scholar
• Samraj AN, Bertrand KA, Luben R, Khedri Z, Yu H, Nguyen D, Gregg CJ, Diaz SL, Sawyer S, Chen X, et al. 2018. Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: total antibody levels are associated with colorectal cancer risk. PLoS One. 13(6):e0197464. doi:10.1371/journal.pone.0197464.
   PubMed Web of Science ®Google Scholar
• Seberger PJ, Chaney WG. 1999. Control of metastasis by Asn-linked, β1-6 branched oligosaccharides in mouse mammary cancer cells. Glycobiology. 9(3):235–241. doi:10.1093/glycob/9.3.235.
   PubMed Web of Science ®Google Scholar
• Sethi MK, Hancock WS, Fanayan S. 2016. Identifying N-glycan biomarkers in colorectal cancer by mass spectrometry. Acc Chem Res. 49(10):2099–2106. doi:10.1021/acs.accounts.6b00193.
   PubMed Web of Science ®Google Scholar
• Sharapov SZ, Tsepilov YA, Klaric L, Mangino M, Thareja G, Shadrina AS, Simurina M, Dagostino C, Dmitrieva J, Vilaj M, et al. 2019. Defining the genetic control of human blood plasma N-glycome using genome-wide association study. Hum Mol Genet. 28(12):2062–2077.
   PubMed Web of Science ®Google Scholar
• Shinozaki E, Tanabe K, Akiyoshi T, Tsuchida T, Miyazaki Y, Kojima N, Igarashi M, Ueno M, Suenaga M, Mizunuma N, et al. 2018. Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker. BMC Cancer. 18(1):406. doi:10.1186/s12885-018-4252-6.
   PubMedGoogle Scholar
• Shu X, Wu L, Khankari NK, Shu XO, Wang TJ, Michailidou K, Bolla MK, Wang Q, Dennis J, Milne RL, et al. 2019. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. Int J Epidemiol. 48(3):795–806. doi:10.1093/ije/dyy201.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. 2021. Cancer statistics, 2021. CA Cancer J Clin. 71(1):7–33. doi:10.3322/caac.21654.
   PubMed Web of Science ®Google Scholar
• Sindhura B, Hegde P, Chachadi VB, Inamdar SR, Swamy BM. 2017. High mannose N-glycan binding lectin from Remusatia vivipara (RVL) limits cell growth, motility and invasiveness of human breast cancer cells. Biomed Pharmacother. 93:654–665. doi:10.1016/j.biopha.2017.06.081.
   PubMed Web of Science ®Google Scholar
• Smith BH, Campbell A, Linksted P, Fitzpatrick B, Jackson C, Kerr SM, Deary IJ, Macintyre DJ, Campbell H, McGilchrist M, et al. 2013. Cohort profile: generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int J Epidemiol. 42(3):689–700. doi:10.1093/ije/dys084.
   PubMed Web of Science ®Google Scholar
• Stanley P, Moremen KW, Lewis NE, Taniguchi N, Aebi M, Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, et al. 2022. N-Glycans. In: Essentials of glycobiology [internet]. 4th edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; Chapter 9.
   Google Scholar
• Stanley P, Schachter H, Taniguchi N. 2009. N-glycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editor. Essentials of glycobiology. 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
   Google Scholar
• Suhre K, Arnold M, Bhagwat AM, Cotton RJ, Engelke R, Raffler J, Sarwath H, Thareja G, Wahl A, DeLisle RK, et al. 2017. Connecting genetic risk to disease end points through the human blood plasma proteome. Nat Commun. 8:14357.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Kuroki Y, Ohtsubo K, Taniguchi N. 2009. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr Res. 344(12):1387–1390. doi:10.1016/j.carres.2009.04.031.
   PubMed Web of Science ®Google Scholar
• Taniguchi N, Kizuka Y. 2015. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res. 126:11–51. doi:10.1016/bs.acr.2014.11.001.
   PubMed Web of Science ®Google Scholar
• Terkelsen T, Haakensen VD, Saldova R, Gromov P, Hansen MK, Stöckmann H, Lingjaerde OC, Børresen-Dale AL, Papaleo E, Helland Å, et al. 2018. N-glycan signatures identified n tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome. Mol Oncol. 12(6):972–990. doi:10.1002/1878-0261.12312.
   PubMed Web of Science ®Google Scholar
• Theodoratou E, Thaçi K, Agakov F, Timofeeva MN, Štambuk J, Pučić-Baković M, Vučković F, Orchard P, Agakova A, Din FV, et al. 2016. Glycosylation of plasma IgG in colorectal cancer prognosis. Sci Rep. 6:28098. doi:10.1038/srep28098.
   PubMed Web of Science ®Google Scholar
• Timoshchuk A, Sharapov S, Aulchenko YS. 2023. Twelve years of genome-wide association studies of human protein N-glycosylation. Engineering. S2095-8099(23)00201-1. doi:10.1016/j.eng.2023.03.013.
   Google Scholar
• Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, Nguyen M, Olsson A, Nawroth PP, Bierhaus A, et al. 2008. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis. 29(10):2035–2043. doi:10.1093/carcin/bgn188.
   PubMed Web of Science ®Google Scholar
• Vučković F, Theodoratou E, Thaçi K, Timofeeva M, Vojta A, Štambuk J, Pučić-Bakovic M, Rudd PM, ,z--Derek L, Servis D, et al. 2016. Igg glycome in colorectal cancer. Clin Cancer Res. 22(12):3078–3086. doi:10.1158/1078-0432.CCR-15-1867.
   PubMed Web of Science ®Google Scholar
• Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, et al. 2018. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nat Genet. 50(7):968–978. doi:10.1038/s41588-018-0132-x.
   PubMed Web of Science ®Google Scholar
• Wu L, Shu X, Bao J, Guo X, Kote-Jarai Z, Haiman CA, Eeles RA, Zheng W, PRACTICAL, CRUK, BPC3, CAPS, PEGASUS Consortia et al. 2019. Analysis of over 140,000 European descendants identifies genetically predicted blood protein biomarkers associated with prostate cancer risk. Cancer Res. 79(18):4592–4598. doi:10.1158/0008-5472.CAN-18-3997.
   PubMed Web of Science ®Google Scholar
• Yang G, Tan Z, Lu W, Guo J, Yu H, Yu J, Sun C, Qi X, Li Z, Guan F. et al. 2015. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy. J Proteome Res. 14(2):639–653. doi:10.1021/pr5006026.
   PubMed Web of Science ®Google Scholar
• Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N. 1995. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc. Natl Acad. Sci. 92(19):8754–8758. doi:10.1073/pnas.92.19.8754.
   PubMed Web of Science ®Google Scholar
• Yue T, Goldstein IJ, Hollingsworth MA, Kaul K, Brand RE, Haab BB. 2009. The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Mol Cell Proteomics. 8(7):1697–1707. doi:10.1074/mcp.M900135-MCP200.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang Y, Qian Y, Wu X, Zhang Z, Liu X, Zhao R, Zhou L, Ruan Y, Xu J, et al. 2014. Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics. PloS one. 9(2):e87978. doi:10.1371/journal.pone.0087978.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Sato Y, Isaji T, Fukuda T, Matsumoto A, Miyoshi E, Gu J, Taniguchi N. 2008. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 275(9):1939–1948. doi:10.1111/j.1742-4658.2008.06346.x.
   PubMed Web of Science ®Google Scholar
• Zhao YP, Zhou PT, Ji WP, Wang H, Fang M, Wang MM, et al. 2017. Validation of N-glycan markers that improve the performance of CA19-9 in pancreatic cancer. Clin Exp Med. 17(1):9–18. doi:10.1007/s10238-015-0401-2.
   PubMed Web of Science ®Google Scholar
• Zhu J, Shu X, Guo X, Liu D, Bao J, Milne RL, Giles GG, Wu C, Du M, White E, et al. 2020. Associations between genetically predicted blood protein biomarkers and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 29(7):1501–1508. doi:10.1158/1055-9965.EPI-20-0091.
   PubMed Web of Science ®Google Scholar
• Zhu J, Wu C, Wu L. 2021. Associations between genetically predicted protein levels and COVID-19 severity. J Infect Dis. 223(1):19–22. doi:10.1093/infdis/jiaa660
   PubMed Web of Science ®Google Scholar